Drug intelligence / Profile preview

Thrombostim

Development stage
Phase 3
Lead developer
South African National Blood Service
Modality
Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Other Cell Types → Cell Therapies
Administration
Topical
01

Overview

**Thrombostim** is a topical, dual-component, human blood-derived wound-healing product developed and manufactured by the South African National Blood Service. It contains lyophilized platelet-rich plasma and lyophilized human thrombin, which are reconstituted and combined at application to form a fibrin-rich coagulum. The thrombin component converts fibrinogen to fibrin and helps generate a local clot matrix, while platelet-rich plasma supplies platelet-derived growth factor and other platelet-associated mediators intended to support tissue repair. It has been evaluated in a Phase 3 study for recalcitrant venous stasis ulcers.

Brand names
Thrombostim
Other names
PRP/thrombin mixturePlatelet Rich Plasma and Thrombin Coagulumtopical Platelet Rich Plasma and Thrombin mixture

Beyond the preview

Go deeper on Thrombostim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thrombostim.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call